- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03412539
Mechanism of Effectiveness of Neurosurgery Treatments for Durable Pain
Study Overview
Status
Conditions
Detailed Description
The participants in the study are patients who undergo surgery to damaged nerve transmission and processing system in the nervous system as part of the routine clinical treatment that will not be affected by the proposed study. Patients who are candidates for procedures are referred from all over the country and undergo a multidisciplinary evaluation in the framework of the Palliative Pain Management Clinic, which operates exclusively in Israel at the Sourasky Medical Center in Tel Aviv.
During the preoperative evaluation, patients will be given an explanation about the possibility of participating in the study. Patients who agree to participate will sign an informed consent form.
Study Type
Expanded Access Type
- Individual Patients
Contacts and Locations
Study Contact
- Name: Ido Strauss, MD
- Phone Number: 972-3-6974949
- Email: idos@tlcmc.gov.il
Study Locations
-
-
-
Tel Aviv, Israel
- Available
- Neurosurgery, Tel-Aviv Sourasky MC
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients undergoing neurosurgical surgery for resistant pain
- Ability to sign informed consent form for participation in the study
- A functional level is sufficient for cooperation and the performance of various tasks before and after surgery, including performing MRI's, answering pain questioners, and neuropsychological evaluations.
Exclusion Criteria:
- Refusal to participate
- Pregnant women
Study Plan
How is the study designed?
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start
Primary Completion
Study Completion
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- TASMC-0354-17-TLV
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Oncology Problem
-
H. Lee Moffitt Cancer Center and Research InstituteLynn Cancer InstituteCompletedOncology ProblemUnited States
-
Andrew Sch umacherCompletedCancer | Oncology ProblemUnited States
-
Richmond University Medical CenterRecruiting
-
Johns Hopkins All Children's HospitalRecruitingPediatric Cancer | Oncology | Disruptive BehaviorUnited States
-
Nova Scotia Health AuthorityNot yet recruitingCognitive Impairment | Frailty | Oncology ProblemCanada
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedKidney Diseases | Hematologic Diseases | Transplantation Infection | Oncology ProblemNetherlands
-
State University of New York at BuffaloRecruitingMedical Oncology | Integrative Oncology | Medical Nutrition TherapyUnited States
-
State University of New York at BuffaloRecruitingMedical Oncology | Integrative Oncology | Medical Nutrition TherapyUnited States
-
MaineHealthTufts Medical CenterRecruitingOncology | Prehabilitation | Surgical OncologyUnited States
-
AmgenCompletedCancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States